Break it Down: Quick access to quick ED fix from LTR Pharma

Stockheads
12 Dec 2024

Stockhead’s Break it Down brings you today’s leading market news in under 90 seconds.

In this episode, host Sarah Hughan tells all on LTR Pharma’s (ASX:LTP) online healthcare platform for Aussie men to access Spontan.

Spontan is a novel nasal spray designed to treat erectile dysfunction, and recent trials have shown a faster absorption than oral treatment.

Tune in to get the latest.

While LTR Pharma is a Stockhead advertiser, it did not sponsor this content.

Explore More

  • Investor Guide: Health & Biotech FY2025 featuring Tim Boreham

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10